Form D · Biotechnology
Fluoresentric, Inc.
Park City, UT · CIK 0001618642
Offering snapshot reported Sep 9, 2014 · SEC filing
- Reported sold
- $500K Offering amount: $500K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Jun 6, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 9, 2014 | Initial | $500,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-224342
$250,000 in Illinois; $250,000 in Indiana
No sales commissions or finders fees will be paid.
Source: Form D, filed Sep 9, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brian Caplin | Director, Executive |
| Stephen Caplin | Director |
| William C Olson | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2700 Homestead Rd Ste 50
Park City, UT, 84098
Park City, UT, 84098